Dassault Systèmes (DSY) Guidance summary
Event summary combining transcript, slides, and related documents.
Guidance summary
3 Feb, 2026Opening remarks and agenda
Preliminary Q2 2024 results and updated full-year outlook were discussed, with a focus on non-IFRS financials and forward-looking statements.
Management acknowledged the preliminary nature of the results and set expectations for a full update on July 25th, with a conference call held on July 9, 2024.
Guidance on key objectives
Full-year 2024 revenue growth guidance revised to 6%-8% (from 8%-10%) due to delayed large deals, with a Q2 revenue shortfall of EUR 30 million.
Second quarter total revenue estimated at €1.495 billion, about 4% y/y growth.
Diluted EPS estimated at €0.30, in line with the objective of €0.30 to €0.31; full-year EPS growth guidance revised to 8%-11%.
No plans to postpone price increases, maintaining alignment with inflation and value discipline.
Commitment to 10%+ midterm revenue CAGR remains, with H2 and Q4 expected to show stronger growth.
Market trends and strategic opportunities
Delays in large transactions, especially in aerospace, defense, and some energy projects, due to complex geopolitical and macroeconomic factors.
Customer demand remains strong, but increased cautiousness in signings; all delayed deals remain in the pipeline.
Medidata and SOLIDWORKS performed in line with objectives; Medidata expected to return to growth in H2.
No significant negative patterns observed in Asia; volatility in China is consistent with past trends.
Latest events from Dassault Systèmes
- Pascal Daloz succeeds Bernard Charlès, driving continuity in Industrial AI and 3D UNIV+RSES.DSY
Investor update23 Feb 2026 - FY25 revenue up 4% to €6,240M, strong recurring/cloud growth; FY26 targets 3–5% growth.DSY
Q4 2025 Investor Call11 Feb 2026 - FY26 targets 3–5% revenue growth, margin expansion, and strong ARR momentum.DSY
Q4 202511 Feb 2026 - Revenue and EPS rose, with robust cloud and 3DEXPERIENCE growth; outlook remains strong.DSY
Q2 20249 Feb 2026 - Q2 revenue up 6%, guidance reaffirmed, strong 3DEXPERIENCE and cloud growth.DSY
Q2 20259 Feb 2026 - Q3 saw 5% revenue growth, margin expansion, and strong recurring revenue momentum.DSY
Q3 20253 Feb 2026 - 5% revenue growth, 30.1% margin, and strong subscription momentum despite Life Sciences headwinds.DSY
Q3 2025 Investor Call3 Feb 2026 - Strong H1 growth from 3DEXPERIENCE and cloud, with robust outlook despite deal delays.DSY
Q2 2024 Investor Call2 Feb 2026 - Q3 revenue up 4% to €1.46B; EPS guidance reaffirmed, with Q4 growth acceleration expected.DSY
Q3 202418 Jan 2026